| Term 
 | Definition 
 
        | s/s - sense of breathlessness, tightness in chest, w/ wheezing, dyspnea (shortness of breath) & cough sometimes caused by allergies. In most cases don't know cause 
 |  | 
        |  | 
        
        | Term 
 
        | chronic inflammatory airway d/o |  | Definition 
 
        | cause immune mediated airway inflammation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | resulting in spasms & activation of inflammatory cells w/ airway inflammation & edema, excessive mucus secrections & plugging, smooth muscle atrophy, all resulting in obstruction of airflow in addition inflammation causes bronchial hyper reactivity to mild triggers (cold air, exercise, smoke) |  | 
        |  | 
        
        | Term 
 
        | metered-dose inhalers (MDI's) |  | Definition 
 
        | 1 to 2 puffs, 1 minute between puffs start inhaling before activation delivers 10% to lungs; if spacer is used - 20% delivered |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CFC - off market by 12/2013 due to ozone damage HFA - hydrofluralkanes |  | 
        |  | 
        
        | Term 
 
        | dry-powder inhalers (DPI's) |  | Definition 
 
        | breath-activated delivers 20% to lungs more than MDI alone |  | 
        |  | 
        
        | Term 
 
        | nebulizer (SVN - small volume nebulizer) |  | Definition 
 
        | creates a mist delivered by face mask or mouth piece several minutes to deliver a 1 puff MDI equivalent |  | 
        |  | 
        
        | Term 
 
        | budesonide (Pulmicort) fluticasone propionate (Flovent) prophylaxis anti-inflammatory (long term tx): "inhaled glucocorticoid" suppresses inflammation, reducing bronchial hyperreactivity; ↓ airway mucus production; ↑ # of bronchial beta2 receptors & their responsiveness to beta2 agonist |  | Definition 
 
        | Route: inhaled Use: prophylaxis of chronic asthma (fixed schedule(daily, BID, etc), not PRN) Effect: ↓ intensity & frequency of asthma attacks AE: oropharyngeal candidiasis (thrush), dysphonia (horse voice)(lessened w/ use of spacer); slow growth in children & adolescents; prolonged therapy - risk of bone loss, cataracts & glaucoma
 |  | 
        |  | 
        
        | Term 
 
        | prednisone prednisolone prophylaxis anti-inflammatory (long term tx): "oral glucocorticoid" similar in action to inhaled glucocorticoids |  | Definition 
 
        | Route: PO Use: prophylaxis of asthma Effect: ↓ intensity & frequency of asthma attacks AE: adrenal suppression; osteoporosis; hyperglycemia; peptic ulcer disease (PUD); suppression of growth (youth) |  | 
        |  | 
        
        | Term 
 
        | zileuton (Zyflo) prophylaxis anti-inflammatory (long term tx): "leukotriene modifier" inhibits leukotriene synthesis (leukotrienes promote bronchoconstriction, mucus production & airway edema) |  | Definition 
 
        | Route: PO Use: prophylaxis & maintenence therapy for asthma Effect: ↓ bronchoconstriction, inflammation, mucus & edema AE: hepatotoxicity to symptomatic hepatitis (reversible) - monitor LFT's (liver function tests); neuropsychiatric effects (depression, anxiety, agitation, abnormal dreams, hallucinations, insomnia, irritiability, restlessness, SI (suicidal ideation)) DD: ↑ theophylline levels; ↑ warfarin levels; ↑ propranolol levels (↓ BP, ↓ HR)
 |  | 
        |  | 
        
        | Term 
 
        | zafirlukast (Accolate) prophylaxis anti-inflammatory (long term tx): "leukotriene modifier" leukotriene antagonist |  | Definition 
 
        | Route: PO (1 hr AC or 2 hr PC) Use: maintenance therapy for chronic asthma Effect: reduced filtration of inflammatory cells; ↓ bronchoconstriction AE: rare - liver injury; common - HA; GI disturbance & some incidence of neuropsych s/s - both infrequent DD: ↑ theophylline & warfarin levels
 |  | 
        |  | 
        
        | Term 
 
        | montelukast (Singulair) prophylaxis anti-inflammatory (long term tx): "leukotriene modifier" leukotriene antagonist |  | Definition 
 
        | Route: PO Use: maintenance therapy for asthma, use in exercise induced asthma Effect: ↓ asthma-related nocturnal awakening (take at HS); ↑ morning lung function; ↓ need for inhaled beta2 agonists AE: no hepatotoxicity DD: none noted at this time
 |  | 
        |  | 
        
        | Term 
 
        | cromolyn (Intal) prophylaxis anti-inflammatory (long term tx): "mast cell stabilizer" prevents histamine release from mast cells, ↓ inflammation |  | Definition 
 
        | Route: MDI; nebulizer Use: prophylaxis for moderate asthma; ineffective for ongoing attack; use prior to allergen exposure; exercise-induced bronchospasm; allergic rhinitis (inflammation of the nasal passage) Effects: ↓ frequency/intensity of asthma attacks AE: safest antiasthmatic
 |  | 
        |  | 
        
        | Term 
 
        | omalizumab (Xoliar) prophylaxis anti-inflammatory (long term tx): "monoclonal antibody" antagonizes IgE; limits the ability of allergens to release histamine |  | Definition 
 
        | Route: SC Use: second line agent for allergy related asthma; last resort AE: injection site irritation (45%), viral infections (23%), URI(upper respiratory infection)(20%), sinusitis (inflammation of the sinus), HA, pharyngitis (inflammation of the pharynx); also a risk for anaphylaxis, cancer used in pts > 12 yrs of age |  | 
        |  | 
        
        | Term 
 
        | albuterol (Proventil), levalbuterol (Xopenex), pirbuterol (Maxair) acute attack tx bronchodilators (short term tx): "beta2-adrenergic agonist" short acting beta agonist (SABA) |  | Definition 
 
        | Route: inhaled (immediate onset, 30-60 min peak) Action: simpathomimetic (stimulates resp); stimulates beta2 receptors in smooth muscle (bronchodilation); suppresses histamine release; ↑ ciliary motility Use: quick relief of ongoing asthma attack & long term control; used prior to exercise as prophylaxis Effect: bronchodilation, relieves bronchospasm AE: systemic effects (tacycardia, angina, tremor), aggravated in excessive dosages
 
 |  | 
        |  | 
        
        | Term 
 
        | formoterol (Fordil), arformoterol (Brovana) acute attack tx bronchodilators (short term tx): "beta2-adrenergic agonist" long acting beta agonist (LABA) |  | Definition 
 
        | Route: PO Action: simpathomimetic (stimulates resp); stimulates beta2 receptors in smooth muscle (bronchodilation); suppresses histamine release; ↑ ciliary motility Use: quick relief of ongoing asthma attack & long term control; used prior to exercise as prophylaxis Effect: bronchodilation, relieves bronchospasm AE: tremors, may activate beta1 receptors in heart; angina, tachy dysrhythmia |  | 
        |  | 
        
        | Term 
 
        | theophylline (Theo-24) "methylxanthine" bronchodilation by relaxing bronchi smooth muscle |  | Definition 
 
        | Route: PO (used for chronic asthma), IV (acute attack) Use: maintenance therapy of chronic stable asthma Effect: ↓ intensity & frequency of asthma attacks; appropriate for nocturnal attacks r/t prolonged effects when used regularly AE: at 20-25 mcg/mL - GI (N, V, diarrhea); insomnia; restlessness Toxcity: above 30 mcg/mL - severe dysrhythmias (v. fib), convulsions; death from cardiorespiratory collapse.  DD: caffeine - intensifies AE of theophylline; cimetidine (Tagamet), fluoroquinolone antibiotics - ↑ levels of theophylline; phenobarbital, phenytoin, rifampin - ↓ levels of theophylline
 |  | 
        |  | 
        
        | Term 
 
        | aminophylline "methylxanthine" |  | Definition 
 
        | theophylline salt; more soluable than theophylline - in solution, becomes theophylline 1 aminophylline = 2 theophylline (dose differently) monitor frequently; therapeutic reange 10-20 mcg/mL |  | 
        |  | 
        
        | Term 
 
        | ipratropium (Atrovent) - short acting tiotropium (Spiriva) - long acting anticholinergic: "atropine derivative" bronchodilator, relieves bronchospasm in COPD; used in asthma |  | Definition 
 
        | Route: MDI (Atrovent) - onset 30 seconds; spinhaler (Spiriva) Use: allergen-induced asthma; exercise-induced bronchospasm (less effective than beta2 agonist, additive effect w/ beta2 agonist) Effect:  bronchodilation AE: dry mouth, irritation of pharnyx; raise intraocular pressure in glaucoma pts
 |  | 
        |  | 
        
        | Term 
 
        | fluticasone/salmeterol (Advair) "glucocorticoid/LABA combination" anti-inflammatory and bronchodilation |  | Definition 
 
        | Use: long term maintenance - reserved for pts not adequatly controlled w/ inhaled glucocorticoid, not initial therapy fixed dose combinations AE: none |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inflammatory d/o of the upper airway, lower airway and eyes s/s: sneezing, rhinorrhea (runny nose), conjuctivitis, sinusitis, asthma; secondary to histamine, leukotriene & prostagliandin release (response to allergies) hay fever; perennial rhinitis (indoor allergens) |  | 
        |  | 
        
        | Term 
 
        | beclomethasone (Beconade) "intranasal glucocorticoid" anti-inflammatory |  | Definition 
 
        | Route: intranasal Use: seasonal & perennial rhinitis Effect: suppresses major s/s of allergic rhinitis - congestion, rhinorrhea, sneezing, nasal pruritis & erythema AE: drying of nasal mucoas; sensation of burning or itching (r/t vehicle), sore throat, epistaxis (severe nose bleed), HA |  | 
        |  | 
        
        | Term 
 
        | diphenhydramine (Benadryl) "antihistamine" histamine receptor antagonist |  | Definition 
 
        | Route: PO Use: prophylaxis for allergic rhinitis & allergic reaction Effect: relieve sneezing, rhinorrhea, nasal pruritis; no ↓ in nasal congestion AE: sedation, anticholinergic effects (dry mouth, C , urinary hesitancy) |  | 
        |  | 
        
        | Term 
 
        | cromolyn sodium (NasalCrom) "intranasal mast cell stabilizer" suppressess histamine release from mast cells |  | Definition 
 
        | Route: intranasal Use: prophylaxis - prevent allergic rhinitis Effect: relieve s/s of allergic rhinitis AE: minimal |  | 
        |  | 
        
        | Term 
 
        | phenylephrine (Neo-synephrine), pseudo ephedrine (Sudafed) "decongestant (sympathomimetic)" stimulates alpha-adrenergic receptors on nasal blood vessels, causes vasoconstriction shrinking swollen membranes   |  | Definition 
 
        | Route: intranasal drops/spray, PO (Sudafed) Use: only relieves stuffiness in allergic rhinitis, no other symptom relief Effect: reduce congestion AE: intranasal (rebound congestion - limit to 3-5 days use); oral (CNS stimulation - restlessness, irritability, anxiety, insomnia; CV effects - vasoconstriction (hazardous in pts w/ HTN or CAD); abuse potential r/t CNS stimulation
 |  | 
        |  | 
        
        | Term 
 
        | montelukast (Singulair) leukotriene antagonist |  | Definition 
 
        | Route: PO Use: seasonal & perennial allergic rhinitis Effect: ↓ nasal congestion AE: rare - neuropsychiatric (agitation, aggression, hallucination, depression, insomnia, restlessness, SI last drug of choice due to AEs |  | 
        |  | 
        
        | Term 
 
        | codiene (Paveral), hydrocodone (Hycodan) "opioid antitussive(cough)" CNS elevation of cough threshold |  | Definition 
 
        | Route: PO (doses are about 1/10 of those used in pain relief) Use: cough suppressant Effect: reduce frequency & intensity of cough AE: respiratory suppression (do not use w/ nocturnal apnea); abuse potential (Schedule II - codeine alone; Schedule V for codeine in antitussive mixtures)
 |  | 
        |  | 
        
        | Term 
 
        | dextromethorphan (Drixoral, Pertussin, Robitussin DM) "nonopioid antitussive" raise cough threshold in CNS |  | Definition 
 
        | Route: PO Use: cough suppressant Effect: reduce frequency & intensity of cough; enhance analgesic effects of opioids (doubles morphine's analgesia) AE: minimal (no euphoria or dependence; no resp depression)
 |  | 
        |  | 
        
        | Term 
 
        | benzonatate (Tessalon) "nonopioid antitussive" derivative of tetracaine & procaine; ↓ sensitivity of resp tract stretch receptors |  | Definition 
 
        | Route: PO capsules (cannot be opened or crushed) Use: cough suppressant Effect: reduce frequency & intensity of cough AE: mild sedation, dizziness; C
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | agent that stimulates the flow of respiratory secretions to yield a "productive" cough guaifenesin (Musinex, Humbid) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | acts directly w/ mucus to make it "watery" and make cough more productive acetylcysteine (Mucomyst) - nebulizer; hypertonic saline (3%) caution: both mucolytics can cause bronchospasm |  | 
        |  |